Associations between cerebral amyloid and changes in cognitive function and falls risk in subcortical ischemic vascular cognitive impairment

Table 1 Descriptive Characteristics

Variable	Exercise group n = 11		Control group n = 11		Total N = 22
	Mean	SD	Mean	SD	Mean	SD
Age	70.00	7.29	73.45	8.47	71.73	7.91
Female sex, No. (%)	3	27.3	4	36.4	7	31.81
MOCA	22.73	2.20	23.91	1.87	23.32	2.08
Waist-to-hip ratio	0.90	0.08	0.93	0.08	0.91	0.08
Body mass index	27.14	6.24	26.75	2.98	26.95	4.78
FCI	3.09	1.81	3.55	1.69	3.32	1.73
Total medications	3.27	3.10	5.00	3.90	4.14	3.55
Beta-blockers, No. (%)	3	27	2	18	5	23
Global PIB BP_ND	0.14	0.24	0.07	0.23	0.10	0.23
WMH volume (mm³)	1277.82^a	1446.90	2569.52^b	3450.16	2004.40^c	2761.15
Baseline Assessments
ADAS-Cog	10.65	4.76	8.61	2.60	9.63	3.88
TMT B-A, sec.	45.07	20.93	55.95	28.14	50.51	24.84
VDST F-B, sec.	2.45	2.88	4.00	2.61	3.23	2.79
Stroop CW-C, sec.	68.33	30.26	54.54	20.02	61.44	26.01
DSST	26.27	8.01	25.27	5.97	25.77	6.91
PPA	0.54	1.50	0.47	0.91	0.50	1.21
Final Assessments
ADAS-Cog	9.57	4.70	6.86	2.77	8.22	4.01
TMT B-A, sec.	76.43	69.32	66.45	51.88	71.44	59.97
VDST F-B, sec.	2.18	1.83	3.27	1.85	2.73	1.88
Stroop CW-C, sec.	66.41	25.91	55.60	32.37	61.00	29.14
DSST	26.09	8.93	23.55	8.47	24.82	8.59
PPA	0.12	1.23	0.54	0.59	0.33	0.96

SD Standard Deviation, MOCA Montreal Cognitive Assessment (max. Score 30), FCI Functional comorbidity index (total number of comorbidities), ADAS-Cog Alzheimer’s Disease Assessment Scale - Cognitive subscale (max. Score of 70), TMT B-A Trail Making Test, Part B minus Part A, VDST F-B Verbal Digit Span Test, Forward minus Backward, Stroop CW-W Stroop Color Words minus Stroop colored x’s, DSST Digit Symbol Substitution Test, PPA Physiological Profile Assessment; ^aExercise group - WMH volume, n = 7; ^bControl group - WMH volume, n = 9; ^cTotal - WMH volume, n = 16

ISSN: 1471-2318